Literature DB >> 16240988

Recent advances in non-viral gene delivery.

Christine C Conwell1, Leaf Huang.   

Abstract

Gene therapy has been deemed the medicine of the future due to its potential to treat many types of diseases. However, many obstacles remain before gene delivery is optimized to specific target cells. Over the last several decades, many approaches to gene delivery have been closely examined. By understanding the factors that determine the efficiency of gene uptake and expression as well as those that influence the toxicity of the vector, we are better able to develop new vector systems. This chapter will provide a brief overview of recent advances in gene delivery, specifically on the development of novel non-viral vectors. The following chapters will provide additional details regarding the evolution of non-viral gene delivery systems.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16240988     DOI: 10.1007/4-431-27879-6_1

Source DB:  PubMed          Journal:  Adv Genet        ISSN: 0065-2660            Impact factor:   1.944


  12 in total

Review 1.  Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.

Authors:  Douglas S Watson; Aaron N Endsley; Leaf Huang
Journal:  Vaccine       Date:  2012-02-02       Impact factor: 3.641

Review 2.  Functional lipids and lipoplexes for improved gene delivery.

Authors:  Xiao-Xiang Zhang; Thomas J McIntosh; Mark W Grinstaff
Journal:  Biochimie       Date:  2011-05-20       Impact factor: 4.079

3.  The effect of charge-reversal amphiphile spacer composition on DNA and siRNA delivery.

Authors:  Xiao-Xiang Zhang; Carla A H Prata; Thomas J McIntosh; Philippe Barthélémy; Mark W Grinstaff
Journal:  Bioconjug Chem       Date:  2010-05-19       Impact factor: 4.774

4.  Macropinocytosis is the major pathway responsible for DNA transfection in CHO cells by a charge-reversal amphiphile.

Authors:  Xiao-Xiang Zhang; Phillip G Allen; Mark Grinstaff
Journal:  Mol Pharm       Date:  2011-03-30       Impact factor: 4.939

5.  Charge-reversal lipids, peptide-based lipids, and nucleoside-based lipids for gene delivery.

Authors:  Caroline M LaManna; Hrvoje Lusic; Michel Camplo; Thomas J McIntosh; Philippe Barthélémy; Mark W Grinstaff
Journal:  Acc Chem Res       Date:  2012-03-22       Impact factor: 22.384

6.  Synthesis, characterization, and in vitro transfection activity of charge-reversal amphiphiles for DNA delivery.

Authors:  Xiao-Xiang Zhang; Carla A H Prata; Jason A Berlin; Thomas J McIntosh; Philippe Barthelemy; Mark W Grinstaff
Journal:  Bioconjug Chem       Date:  2011-04-01       Impact factor: 4.774

7.  Identification of novel superior polycationic vectors for gene delivery by high-throughput synthesis and screening of a combinatorial library.

Authors:  Mini Thomas; James J Lu; Chengcheng Zhang; Jianzhu Chen; Alexander M Klibanov
Journal:  Pharm Res       Date:  2007-03-24       Impact factor: 4.200

8.  Cytotoxic impacts of linear and branched polyethylenimine nanostructures in a431 cells.

Authors:  Vala Kafil; Yadollah Omidi
Journal:  Bioimpacts       Date:  2011-06-09

Review 9.  Gene delivery by cationic lipid vectors: overcoming cellular barriers.

Authors:  Inge S Zuhorn; Jan B F N Engberts; Dick Hoekstra
Journal:  Eur Biophys J       Date:  2006-09-22       Impact factor: 2.095

Review 10.  Gene therapy of the rheumatic diseases: 1998 to 2008.

Authors:  Christopher H Evans; Steven C Ghivizzani; Paul D Robbins
Journal:  Arthritis Res Ther       Date:  2009-01-30       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.